staurosporine aglycone has been researched along with Carcinoma, Hepatocellular in 2 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakayama, T | 2 |
| Hashimoto, Y | 2 |
| Kaneko, Y | 2 |
| Yoshida, M | 1 |
| Beppu, T | 1 |
| Ohmi, K | 1 |
| Yamashita, S | 1 |
| Nonomura, Y | 1 |
| Kurokawa, K | 2 |
2 other studies available for staurosporine aglycone and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
K252a: a new blocker of the cell-cycle at G1 phase in a human hepatoma cell line.
Topics: Carbazoles; Carcinoma, Hepatocellular; Cell Division; DNA; Flow Cytometry; G1 Phase; Gene Expression | 1993 |
K252a inhibits the phosphorylation of pRb without changing the levels of G1 cyclins and Cdk2 protein in human hepatoma cells.
Topics: Carbazoles; Carcinoma, Hepatocellular; CDC2-CDC28 Kinases; Cell Cycle; Cell Line; Cyclin D1; Cyclin- | 1996 |